Montelukast in RSV-bronchiolitis

scientific article published in February 2004

Montelukast in RSV-bronchiolitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1164/AJRCCM.169.4.952
P698PubMed publication ID14766663
P5875ResearchGate publication ID8882477

P50authorHans BisgaardQ37615680
P2860cites workA randomized trial of montelukast in respiratory syncytial virus postbronchiolitisQ44198475
Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?Q44294567
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectbronchiolitisQ424227
P304page(s)542-543
P577publication date2004-02-01
P1433published inAmerican Journal of Respiratory and Critical Care MedicineQ4744267
P1476titleMontelukast in RSV-bronchiolitis
P478volume169

Reverse relations

cites work (P2860)
Q37110768Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation
Q92061415Asma infantil y del lactante
Q34623135Asthma in preschool children: the next challenge
Q44935829Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy
Q41867295Montelukast as Monotherapy for Pediatric Asthma
Q36444085Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities
Q37857806Respiratory syncytial virus prevention and therapy: past, present, and future
Q41653037Urinary leukotriene E4 levels in atopic and non-atopic preschool children with recurrent episodic (viral) wheezing: a potential marker?

Search more.